Evidence map›Paper›PMID 39329188›Full record

ArticleJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2025

Prevalence of restless legs and association with patient-reported outcome measures in myasthenia gravis.

Mohanad AlGaeed, Tarrant McPherson, Ikjae Lee, Michelle Feese, Inmaculada Aban, Gary Cutter, Henry J Kaminski, Elias G Karroum

Abstract read
In one paragraph

Article in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mohanad AlGaeedDepartment of Neurology & Rehabilitation Medicine, The George Washington University School of Medicine and Health Sciences, Washington, DC.
Tarrant McPhersonDepartment of Biostatistics and Bioinformatics, Emory University, Atlanta, Georgia.
Ikjae LeeThe Neurological Institute of New York, Columbia University, New York, New York.
Michelle FeeseDepartment of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama.
Inmaculada AbanDepartment of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama.
Gary CutterDepartment of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama.
Henry J KaminskiDepartment of Neurology & Rehabilitation Medicine, The George Washington University School of Medicine and Health Sciences, Washington, DC.
Elias G KarroumDepartment of Neurology & Rehabilitation Medicine, The George Washington University School of Medicine and Health Sciences, Washington, DC.

Funding

Rare Disease Network for Myasthenia GravisU54NS115054 · NINDS · GEORGE WASHINGTON UNIVERSITY · PI HENRY J KAMINSKI · 2019 to 2026
$11.9M
NINDS NIH HHS U54 NS115054
6 · The paper itself

Abstract

STUDY

objectivesInflammatory and immune mechanisms are considered in restless legs syndrome (RLS) pathophysiology with several autoimmune diseases associated with RLS. There is a paucity of studies examining RLS prevalence in myasthenia gravis (MG), an autoimmune neuromuscular disease. This study investigated RLS prevalence and association with patient-reported measures in a large registry of participants with MG using a validated RLS diagnostic questionnaire.

methodsThe Myasthenia Gravis Foundation of America MG Patient Registry is used on a semiannual basis to survey participants with MG. Patients aged ≥ 18 years, living in the United States, and answering "yes" to physician diagnosed MG were invited by email to enroll in an RLS-customized web-based survey. Collection of data included demographics, disease variables, patient-reported measures with a simple depression scale, MG-quality of life-15 revised, MG-activities of daily living instruments, and 13-item short-form Cambridge-Hopkins diagnostic questionnaire for RLS. Multivariable logistic regression models explored the association between RLS and MG variables of interest.

resultsA total of 630 eligible participants with MG (age: 62.8 ± 13.2; 54.9% female; 91.6% White) completed the survey. The overall prevalence of RLS was 14.8%. The prevalence of clinically significant RLS was 8.4%. The odds of having RLS were increased with higher (worse) MG-activities of daily living, MG-quality of life-15 revised, and depression scores. History of "thymic tumor with thymectomy" and "continuous positive airway pressure therapy" were also independent predictors of RLS.

conclusionsRLS is common in patients with MG and is associated with worse functional status, quality of life, and depression. The thymus could play a key role in an autoimmune process associating MG with RLS. CITATION: AlGaeed M, McPherson T, Lee I, et al. Prevalence of restless legs and association with patient-reported outcome measures in myasthenia gravis.

Indexed as

Myasthenia GravisPatient Reported Outcome MeasuresRestless Legs SyndromeActivities of Daily LivingAdultAgedFemaleHumansMaleMiddle AgedPrevalenceQuality of LifeRegistriesSurveys and QuestionnairesUnited Statesassociationmyasthenia gravisprevalencerestless legs syndrome

Identifiers

PMID39329188
PMCPMC11789237

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.